Home Blog Page 202

Blog

Pharma Marketing Blog

Random

Vytorin Study Stallin’ – Notes from the Field Hands

Pharma Guy - November 26, 2007

Why are ED drug sales falling?

Pharma Guy - December 5, 2005

My Twitter Audience as of Dec 2015

Pharma Guy - December 17, 2015

Why unbranded ads don’t work

Pharma Guy - November 4, 2005

Transparency Vs. Translucency in Reporting Physician Payments

Pharma Guy - February 3, 2010

Generation X Pharma Reps

Pharma Guy - February 13, 2006

Is Pharma Part of Problem or Solution to Current State of...

Pharma Guy - February 15, 2012

What’s Behind AstraZeneca’s New Push for FDA Preview of DTC Ads?

Pharma Guy - April 28, 2008

Drug Ads from the Doctor’s Perspective

Pharma Guy - September 18, 2008

Pfizer Donates Animal Health Products to Haiti

Pharma Guy - January 20, 2010

1...201202203...241 Page 202 of 241

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Pharmaceutical professional using AI-driven tools to optimize healthcare content with digital brain interface and data analytics

The Algorithmic Gatekeeper: How Pharma Marketers Can Stay Visible in AI-Filtered...

April 20, 2026

Robotic hand holding a capsule in a digital pharma lab with compliance shield and AI data interface

When AI Speaks for Your Brand: What Pharma Marketers Must Do...

April 20, 2026

From Messaging to Meaning: Why Pharma Marketing Needs a Stronger Point...

April 17, 2026